BriaCell Therapeutics Cor...
(BCTXW)
undefined
undefined%
At close: undefined
0.34
-0.03%
After-hours Dec 13, 2024, 04:03 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 |
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -4.79M | -23.27M | -15.29M | -6.97M | -3.61M | -4.73M | -3.82M | - | -1.67M | -1.44M | -437.27K | -424.26K | -1.20M | -1.05M | -324.57K | -233.87K | -114.12K | -129.06K | -8.58K |
Interest Income | - | 891.21K | 136.73K | 3.15K | - | 9.13K | 12.27K | - | 3.63K | 7.09K | 12.00K | 16.90K | 38.01K | 13.36K | 2.90K | 2.73K | - | - | - |
Pretax Income | -4.79M | -20.30M | -11.55M | 3.69M | 1.38M | 946.42K | 1.07M | - | -1.70M | -2.68M | -8.15M | -368.69K | -995.72K | -1.09M | -903.64K | -231.54K | - | - | - |
Net Income | -4.79M | -20.30M | -11.55M | 3.69M | 1.38M | 946.42K | 1.07M | - | -1.70M | -2.68M | -8.15M | -368.69K | -995.72K | -1.08M | -900.74K | -228.81K | -98.93K | -116.41K | -8.58K |
Selling & General & Admin | 6.15M | 7.94M | 7.27M | -3.67M | -1.37M | -932.17K | -1.05M | - | 942.02K | 1.33M | 436.17K | 423.86K | 556.06K | 1.05M | 323.27K | 203.86K | 114.12K | 129.06K | 8.58K |
Research & Development | 27.18M | 15.34M | 8.02M | 1.32M | 2.22M | 3.74M | 2.39M | - | 723.43K | 105.82K | - | - | - | - | - | - | - | - | - |
Other Expenses | - | - | - | - | -58.98K | 319.86K | -312.92K | - | - | - | - | - | - | - | - | 2.33K | - | - | - |
Operating Expenses | 33.33M | 23.27M | -3.39K | -3.69M | -1.38M | -946.42K | -1.07M | - | 1.67M | 1.44M | 437.27K | 424.26K | 551.84K | 1.05M | 324.57K | 233.87K | 114.12K | 129.06K | 8.58K |
Interest Expense | - | - | 979.00 | 46.09K | 27.00K | 23.82K | 15.63K | - | - | - | - | - | - | - | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | - | 23.27M | -3.39K | -3.69M | -1.38M | -946.42K | -1.07M | - | 1.67M | 1.44M | 437.27K | 424.26K | 551.84K | 1.05M | 324.57K | 233.87K | 114.12K | 129.06K | 8.58K |
Income Tax | - | -152.62K | 979.00 | 6.58M | -72.25K | 343.74K | -331.40K | - | 29.24K | 1.24M | 7.71M | -55.56K | 443.88K | 25.60K | 576.17K | -2.73K | 98.93K | 116.41K | 8.58K |
Shares Outstanding (Basic) | 16.45M | 15.52M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Diluted) | 16.45M | 15.52M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS (Basic) | -0.29 | -1.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS (Diluted) | -0.29 | -1.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | -4.79M | -22.37M | -11.50M | 3.71M | 1.40M | 960.68K | 1.08M | - | -1.63M | -191.61K | 7.28M | -462.53K | -68.23K | -1.01M | 255.79K | -233.72K | -114.12K | -129.06K | -8.58K |
Depreciation & Amortization | - | 15.27K | 15.27K | 15.26K | 15.26K | 14.25K | 12.97K | 232.68 | 907.21 | 434.31 | 1.11K | 392.08 | 1.72K | 2.51K | 1.29K | 154.20 | - | - | - |